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ARTICLE
Development of a Parsimonious Design for Optimal 
Classification of Exclusive Breastfeeding
Zheng Liu1,2,*, Aly Diana3,4, Christine Slater5, Thomas Preston6, Rosalind S. Gibson3, Lisa Houghton3 and Stephen B. Duffull1
A deuterium oxide dose-to-mother (DTM) technique is used to determine if an infant is exclusive breastfeeding (EBF). However, 
the DTM method is intensive, requiring seven paired mother–infant samples during a 14-day study period. The purpose of this 
study was to develop a field-friendly protocol. Data from 790 mother–infant pairs from nine countries were analyzed using a 
Markov chain Monte Carlo method with Stan. The data were split into (i) model building (565 pairs) and (ii) design evaluation 
(225 pairs). EBF classification was based on a previously published cut-off for nonmilk water intake. Classification based 
on the full design was the reference (gold standard classification). The receiver operating characteristics of parsimonious 
designs were used to determine an optimal parsimonious classification method. The best two postdose windows (days 7–9 
and 13–14) yielded optimal categorization with similar performance in the design evaluation data. This postdose two-sample 
design provided 95% sensitivity and specificity when compared with the full design.
The World Health Organization recommends exclusive 
breastfeeding (EBF) of infants for the first 6 months of life 
for optimal health, growth, and development.1 EBF is de-
fined as no food or drink other than breastmilk with the 
exception of necessary medicines, vitamin and/or mineral 
supplements, and oral rehydration solutions.1 Although the 
significance of EBF during the beginning of life has been 
specified as a global health priority, the prevalence of EBF 
remains low.
In 2012, the 65th World Health Assembly set a global tar-
get to increase EBF rates in the first 6  months after birth 
from 38% to at least 50% by 2025.2 As a result, the accurate 
assessment of EBF rates is critical to evaluating progress. 
To date, the assessment of EBF at the population level has 
been based on mother or caregiver reporting, which risks re-
call and social desirability bias.3–5 To alleviate this problem, it 
has become increasingly common to employ more objective 
methods to quantify EBF using the deuterium oxide (D2O) 
dose-to-mother (DTM) technique.6–8 In this technique, D2O 
is administered orally to the mother, which is then trans-
ferred to her child via lactation. The kinetics of D2O in the 
mother and her child are monitored through saliva sam-
ples. In our recent work, Liu et al.,9 a nonlinear hierarchical 
model was developed describing the kinetics of D2O in the 
mother and her child and identified a criterion for determina-
tion of EBF. The criterion was defined by the mass of water 
1 School of Pharmacy, University of Otago, Dunedin, New Zealand; 2 School of Medicine and Public Health, Hunter Medical Research Institute, University of Newcastle, 
Rochedale, New South Wales, Australia; 3 Department of Human Nutrition, University of Otago, Dunedin, New Zealand; 4 Division of Medical Nutrition, Faculty of 
Medicine, Universitas Padjadjaran, Bandung, Indonesia; 5 Independent Consultant, Cumbria, UK; 6 Scottish Universities Environmental Research Centre, University of 
Glasgow, Glasgow, UK. Correspondence: Zheng Liu (liuzhengfin@gmail.com)
Received: December 10, 2018; accepted: April 18, 2019. doi:10.1002/psp4.12428
Study Highlights
WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC?
✔  The advantages of exclusive breastfeeding are well 
known. The deuterium oxide dose-to-mother (DTM) 
technique is an objective method to quantify exclu-
sive breastfeeding (EBF) practice and to classify the 
mother–infant pair as EBF or non-EBF. However, the 
DTM protocol is intensive and not field friendly, requir-
ing  seven postdose samples during a 14-day study 
period.
WHAT QUESTION DID THIS STUDY ADDRESS?
✔  This study builds on previous work where a cut-off 
value for non–milk-based water intake was determined. 
In this work, a series of field-friendly streamlined designs 
were developed for optimal classification of mother–infant 
pairs as EBF or non-EBF.
WHAT DOES THIS STUDY ADD TO OUR KNOWLEDGE?
✔  As an example of an optimal classification experiment, 
these designs identified and optimally classified mother–child  
pairs into EBF or non-EBF categories, which has  important 
population-level public health implications. 
HOW MIGHT THIS CHANGE DRUG DISCOVERY, 
DEVELOPMENT, AND/OR THERAPEUTICS?
✔  As an important field tool, the parsimonious designs will 
minimize the burden of field studies and allow for the im-
proved monitoring and evaluation of breastfeeding rates 
and the evaluation of public health support strategies.
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intake (denoted Rs) by the infant from sources other than via 
breastmilk and insensible intake with a value of 86.6 g/day. 
This value is the lowest mass of water intake that can be 
determined reliably using the DTM method that can be used 
as the basis for the classification of mother–infant pairs as 
EBF or non-EBF.
Although there are several advantages of the DTM deu-
terium technique (e.g., relatively noninvasive with known 
performance characteristics9), it is not ideal as the sampling 
protocol requires intensive sampling for 14 days following 
a single maternal dose of D2O. A less intensive or shorter 
follow-up would greatly enhance the utilization of this 
method for the determination of EBF and non-EBF charac-
teristics in populations of interest.
The aim of this study was to develop a parsimonious DTM 
deuterium protocol that classifies mother–infant pairs as 
EBF or non-EBF with optimal operating characteristics. It is 
intended that this protocol could then be taken into future 
field studies for use in low-income countries to determine 
the EBF characteristics in regions of interest and the influ-
ence of public health interventions.
METHODS
The methods (and results) are divided into five sections. 
The data used for this analysis are described in the Data 
section. The section titled “Model Building and Selection” 
outlines the model-building process. “Classification of 
Mother–Infant Pairs” classifies the mother–infant pairs as 
EBF or non-EBF, and “Development of Optimal Allocation 
Designs” outlines the development and assessment of 
the streamlined designs. In the section titled “Evaluation 
of the Selected Streamlined Designs,” the allocation 
characteristics of the best streamlined design(s) were 
evaluated via application to a separate data set.
The model for deuterium used in this study was based on 
our previous work.9 Briefly, the best model was described 
by two-linked, one-compartment models (for mother and 
infant, respectively). The model was built on data that arose 
from closely controlled data arising from exclusive breast-
feeding mothers. The purpose of the model building was 
to evaluate the estimate of the cut-off value of water intake 
from sources other than breast milk (termed Rs) to make 
the distinction between EBF and non-EBF in future stud-
ies. The identified Rs cut-off value was 86.6 g/day, which 
is used in this study to determine the exclusivity of breast-
feeding practices. A summary of the model and the method 
for calculating Rs from the parameters are provided in 
Supplementary Material S1.
Data
In this work, the data were available from the following 
two sources: (i) a calibration study and (ii) a composite 
field study. The calibration study has been presented in 
Liu et al.9 (demographics are provided in Table 1 in this 
article). The composite field study was a combination 
of a series of studies conducted in eight countries (Sri 
Lanka, South Africa, Ghana, Thailand, India, Guatemala, 
Kenya, and Chile). The dosing and sampling methods in 
all of the studies were based on the protocol described 
by the International Atomic Energy Agency.8 The dose of 
D2O administered to the mothers ranged from 6–60 g as 
a single dose with the choice dependent on the sensi-
tivity of the measurement techniques used in the partic-
ular field study. The measurement of D2O was either by 
isotope-ratio mass spectrometry or Fourier-transformed 
Table 1. Description of the total data and the split data 
Contents Field Calibration
Model building (two-thirds 
field + calibration)
Design evaluation 
(one-third field) All
Subjects, no. 677 113 565 225 790
Dose, g 30 (6–60) 30 (30–30) 30 (6–60) 30 (6–60) 30 (6–60)
Baby age, mo 3.4 (2.9–5.5) 3.3 (2.6–3.7) 3.4 (2.9–5.4) 3.3 (2.9–5.5) 3.4 (2.9–5.5)
Baby WT start, kg 6.4 (5.4–7.3) 5.9 (5.5–6.4) 6.2 (5.5–7.2) 6.3 (5.4–7.4) 6.3 (5.4–7.2)
Baby WT end, kg 6.7 (5.7–7.5) 6.2 (5.8–6.7) 6.5 (5.8–7.4) 6.6 (5.8–7.6) 6.5 (5.7–7.4)
Mother age, y 27 (22–31) 26 (21–30) 26 (21–31) 27 (22–31) 26 (21–31)
Mother WT, kg 58 (51–66) 52 (49–60) 56 (50–64) 58 (53–67) 57 (51–65)
Baby female, % 31 53 36 28 34
Baby male, % 35 47 36 38 36
Baby unknown, % 34 0 27 34 29
IRMS, % 37 0 29 40 32
FTIR, % 62 100 71 60 67
South Africa, % 19 0 15 19 16
Thailand, % 25 0 20 25 22
Kenya, % 28 0 23 28 24
Indonesia, % 1 100 20 0.5 15
Other countries, %a 27 0 21 27 23
Row “Dose” is median (range); rows “Baby Age,” “Baby WT Start,” “Baby WT End,” “Mother Age,” and “Mother WT” are median (interquartile range).
FTIR, Fourier-transformed infrared spectrometry; IRMS, isotope-ratio mass spectrometry; WT, weight.
aOther countries: Sri Lanka, Ghana, India, Guatemala, Chile.
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infrared spectrometry. The isotope-ratio mass spectrom-
etry has greater sensitivity for the measurement of deu-
terium, and in these studies the D2O doses were <30 g, 
and for the lower sensitivity for the Fourier-transformed 
infrared spectrometry studies, the D2O dose was ≥30 g.
Model building and selection
All modeling was performed in a fully Bayesian approach 
using Stan (version 2.12.0; Stan Development Team, New 
York, NY) with rstan (version 2.11.1) interface compiled on 
C++ (GCC 4.6.3) and run with R (version 3.3.1; R Foundation 
for Statistical Computing, Vienna, Austria). The structural and 
statistical models are presented in Liu et al.9 (Of note, Stan 
code is available in Supplementary Material S4.) Model 
building here was limited to the further assessment of the re-
sidual error models and investigating covariate relationships.
Both additive and combined residual error models were 
considered, the additive model is presented by Eq. 1 and the 
combined model by Eq. 2
where var(.|.) represents the marginal variance of the obser-
vation given the model prediction (ŷ), yij is the jth observed 
concentration for the ith individual, f is the structural model pre-
dicted concentration, and σ is the residual standard deviation.
Covariate models were expressed as Eq. 3 for continuous 
covariates and Eq. 4 for categorical covariates.
where θ1 and θ2 are the population regression coefficients 
when a covariate was included in the model, ln (θ̄i ) represents 
the natural log of the expected value for an individual with 
those characteristics, covi is the covariate value of the ith 
individual, and covmedian is the median continuous covariate 
over the population.
Bayesian analysis settings and the model evalua-
tion  criteria in this study are the same as described 
in our  previous work, Liu et  al.9, and are presented in 
Supplementary Material S2.
Classification of mother–infant pairs
Mother–infant pairs were classified as exclusive or non-
exclusive on the basis of their individual posterior distri-
butions of Rs (the parameter that relates to the quantity of 
water intake rate from sources other than breastmilk). The 
individual mother–infant pair’s posterior distribution of Rs 
was determined based on the fit of the best model to the 
DTM D2O data from the model-building data set (this is 
also termed the reference data set). The criterion defining 
EBF was determined in our recent work, Liu et al.9 to be at 
86.6 g/day. The determination of exclusivity was according 
to the following classification:
Note that the key public health problem depends on accu-
rately determining the nonexclusivity of breastfeeding practice 
to appropriately focus regional interventions. Hence, we have 
taken a conservative approach to ensure when classifying a 
mother–infant pair as non-EBF, and this is considered at a 
posterior probability of 90% or greater.
A graphical presentation of the classification is provided 
in Figure 1.
Development of optimal allocation designs
We approach the development of parsimonious designs 
to classify mother–infant pairs as EBF or non-EBF as an 
optimal classification problem. The approach was divided 
into the following two parts: (i) selecting streamlined de-
signs and (ii) determining the operating characteristics of 
the selected streamlined designs. For the first part, the final 
model (from the Model Building and Selection section) was 
fitted to each streamlined design data set, and the posterior 
distribution of Rs was computed for each mother–infant pair. 
In the second part, each mother–infant pair was reclassified 
as EBF or non-EBF, and the operating characteristics of the 
allocation based on the streamlined design were compared 
to the classification from the reference design. The refer-
ence design denotes the full DTM design, which in this work 
is considered to provide the “gold standard” classification 
of EBF.
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(3)ln (θ̄i )= ln (θ1)+θ2 ln
covi
covmedian
(4)ln (θ̄i )= ln (θ1)+covi ln (θ2)
(5)Pr (Rs>86.6g/day)>0.9 non-EBF else EBF
Figure 1. Graphic illustration of exclusive breastfeeding (EBF) or non-EBF judgment criteria. The probability scale (Pr) is the probability 
of being non-EBF (i.e., Pr non-EBF = Y). Study pair 1 is classified as EBF (i.e., the probability of being non-EBF is essentially 0), study 
pair 2 is also classified as being EBF (because the probability of being non-EBF is  <  0.9), study pair 3 is classified as non-EBF 
(with Pr > 0.9); and study pair 4 is non-EBF (with Pr = 1). Rs, water intake rate from sources other than breastmilk.
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Selecting streamlined designs. This work involves the 
consideration of five data sets. The data sets represented 
in items 4 and 5 are considered in the evaluation of the 
streamlined designs.
1. Model building data set. This data set consists of 
the whole calibration data set and two-thirds of the 
composite field study data. This was considered 
the reference (or gold standard) data set. Of note, 
this data set is unbalanced in terms of the number 
of mother–infant pairs who provide samples during 
the duration of the study days.
2. Imputed full data set. This is an extension of the model-
building data set with imputed missing data to con-
struct a fully balanced design in terms of the number 
of samples per individual mother–infant pairs per day. 
A single imputation method was used where the miss-
ing data were imputed with the posterior mean value of 
the data given the dose of D2O, the kinetic model, and 
the relevant covariates and sample time.
3. Streamlined data sets. These represent the combina-
torial possibilities of streamlined data sets that could 
exist in a future field study. Each of these data sets was 
formed by nonparametric bootstrap from the imputed 
full data set. The operating characteristics of each of 
these data sets is considered in a pseudo-exhaustive 
search.
4. Design evaluation data set. This data set consists of 
one-third of the composite field study data. Of note, 
this data set is unbalanced in terms of the number of 
mother–infant pairs who provide samples during the 
duration of the study days.
5. Imputed full design evaluation data set. This is an ex-
tension of the design evaluation data set with imputed 
missing data so that it is now fully balanced with re-
gard to the samples per individual per day. A single 
imputation method was used where the missing data 
were imputed with the posterior mean value of the data 
given the dose of D2O, the kinetic model, and relevant 
covariates and sample time.
Streamlined data sets were generated by sampling 
with replacement from the imputed full data set. Each 
streamlined data set consisted of the same number of 
mother–infant pairs as in the model-building data set but 
with fewer paired saliva samples from the mother and 
child. Two types of streamlined designs were considered. 
The first, streamlined design A, represents a limited sam-
ple design where the paired samples could be taken on 
any day from 1–14. The maximum number of paired sa-
liva samples was set to 3. The second, streamlined de-
sign B, represents a limited study duration design (i.e., 
approximately within a week) where the maximum study 
duration could be 7, 6, 5, 4, or 3 consecutive study days. 
In this study, all of the possible examples of the stream-
lined design (full permutation) were investigated and their 
operating characteristics were evaluated. Each design 
was generated once, indicating that the corresponding 
categorization result was dependent on that local design 
only.
Priors for streamlined designs. It is noted that some 
streamlined designs will have fewer observations per 
individual pair than there are structural parameters to 
estimate (i.e., four parameters per individual model fitting). 
This results in a situation in which the model would 
traditionally be considered not identifiable. In a Bayesian 
sense, this would result in the posterior distribution of the 
unidentifiable parameters being the same as the prior, 
i.e., the data would provide no information on particular 
parameters. In a Markov chain Monte Carlo analysis, this 
may result in poor convergence properties of the chains. To 
accommodate this, three different priors could be used in 
the streamlined analyses. 
1. Low-information prior—using the low-information prior 
for the four fitted parameters (i.e., rate constant, 
describing D2O total elimination from the mother 
compartment (kmm), D2O volume of distribution in 
mother compartment (Vm),  H2O clearance rate from 
mother to infant (CLmb) and H2O clearance rate from 
infant  (CLbo)). This is the same prior as used for the 
base model analysis. These results are presented 
in Supplementary Material S3. 
2. Informative prior—using an informative prior for the 
four fitted parameters. Here, the prior was set to the 
posterior of the base model analysis. These results are 
presented in Supplementary Material S3.
3. Mixed prior—using an informative prior for kmm and Vm 
and a low-information prior for CLmb and CLbo. Both CLmb 
and CLbo are strongly influential in the estimate of 
Rs
9, and hence the low-information prior provides more 
opportunities for the data to inform their values.
Streamlined design evaluation
Chain stability and convergence. Chain stability 
and convergence are important criteria for evaluating 
streamlined designs. The streamlined design is considered 
to be valid only if the chains appear to superimpose well, 
indicating good mixing and a stable solution. A detailed 
discussion for this was presented in Liu et al.9
Operating characteristics of the streamlined designs. 
It should be noted that these analyses are designed to 
provide the best estimate of the individual Rs rather than the 
population Rs. Hence, any design outcome must consider 
the correct classification characteristics of the individual.
The characteristics (sensitivity and specificity) of the allo-
cation of mother–infant pairs to EBF or non-EBF categories 
for each streamlined design were compared to classification 
according to the reference design. The characteristics were 
defined as,
“All Positives” is the total number of non-EBF pairs, and “All 
Negatives” is the total number of EBF pairs identified with 
Sensitivity=
True Positives
All Positives
Specificity=
True Negatives
All Negatives
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the reference design. “True Positives” represents the total 
number of non-EBF pairs identified with the streamlined de-
sign that were also considered non-EBF by the reference de-
sign and the corollary for the “True Negatives.” Streamlined 
designs A and B can then be compared in terms of their 
operating characteristics.
EVALUATION OF THE SELECTED STREAMLINED 
DESIGNS
The streamlined designs A and B were evaluated using the 
design evaluation data set (consisting of one-third of the 
composite data set that was not used in the original model 
building), with the design evaluation data set providing the 
reference classification.
The reference classification of mother–infant pairs to the 
EBF or non-EBF categories was determined by the follow-
ing steps. The model (developed from the Model Building 
and Selection section) was fitted to the design evaluation 
data set, and the posterior distribution of Rs was calculated 
for each mother–infant pair. Each mother–infant pair was 
then classified as EBF or non-EBF based on Eq. 5. From the 
imputed full design evaluation data set, the best stream-
lined designs A and B were extracted, the model was fitted 
to these data sets, and their operating characteristics were 
evaluated and compared to the operating characteristics of 
those corresponding to streamlined designs A and B.
RESULTS
Data
After excluding two pairs as subject outliers (defined as 
CLbo > 40% of child body weight; see details in Liu et al.
9), the 
final pooled data set was split into the model-building data 
set or the design evaluation data set. The characteristics of 
the study pairs are summarized and presented in Table 1. 
In total, the model-building data set contains 565 mother–
infant pairs with 6,485 observations. The design evaluation 
data set contains 225 pairs with 2,481 observations.
Model building and selection
Additive and combined error models and covariates were 
tested, and the model performance was evaluated quan-
titatively and graphically. The criteria for choosing error 
models, covariates, and model selection are described in 
Supplementary Material S4.
The best error model was the combined error model, with 
country as covariate to accommodate the different assay 
methods. In addition, mother’s weight (MWT) on her volume 
of distribution (Vm) and infant’s weight (BWT) on the CLbo were 
included in the best final model as presented by Eqs.  8 and 9.
where i is the ith individual and 70 kg and 5 kg are the me-
dian value of mother’s and infant’s weights, respectively.
The mean and 95% credible interval of each individual’s 
posterior distributions of the parameter values (kmm, Vm, 
CLmb, and CLbo) and the calculated posterior distribution of Rs 
are provided in Supplementary Material S5. The sampling 
chains of the best final model were superimposed and well 
mixed (diagnostics not shown), and Rhat (measure of the ratio of 
between and within chain variability) values of all the estimated 
para meters were close to 1.0 (see Supplementary Material S5), 
both of which suggest that a stationary solution was found. 
Individual visual predictive checks (iVPCs) for each mother–in-
fant pair were plotted to assess the final model performance. 
Each iVPC describes the observations satisfactorily. A total 
of 31 randomly selected iVPC graphics are displayed, and 9 
are presented in Figure 2, and the remaining 24 are provided 
in Supplementary Material S6. In addition, visual predic-
tive check plots at the population level are also presented in 
Supplementary Material S6 to illustrate the overall model 
performance.
Classification of mother–infant pairs in the  
model-building data set (gold standard)
Each mother–infant pair was classified as EBF or non-EBF 
based on their posterior distribution of Rs. Classification 
according to the posterior distribution of the individual Rs 
values from this data set was considered the reference 
(i.e., the gold standard) for computation of the operat-
ing characteristics of the streamlined designs A and B. 
Classification details are provided in Table 2.
Development of optimal classification designs
Selecting streamlined designs. To generate different 
streamlined designs, a balanced data set is needed. Each 
individual pair of the 565 mother–infant pairs in the model-
building data set provides an observation for each day. 
However, the model-building data set itself is unbalanced, 
and it cannot be used directly to sample streamlined 
designs. On the basis of days 1, 2, 3, 4, 5, 6, 7, 8, 9, 13, 
and 14, the imputed full data set was created. The detailed 
procedures and rationale of creating the imputed full data 
set is described in Supplementary Material S7. Figure 3 
shows a schematic of the imputed full data set, in which 
each individual pair of the 565 mother–infant pairs in the 
model-building data set provides an observation for each 
day. Missing values were imputed at their posterior mean. 
It is assumed that missing values occurred completely 
at random. The imputed full data set can now be used to 
sample possible streamlined designs.
Applied priors for streamlined designs. Three different 
priors were considered in this study. Details on the low 
information and informative prior that were considered are 
presented in Supplementary Material S3 for comparison. 
In this study, we concentrated on the mixed prior, which 
is presented in Table 3. The rationale for focusing on the 
mixed prior is described in the Discussion.
Streamlined design evaluationSensitivity and specificity for 
the streamlined designs. A total of 11 one-sample designs 
(i.e., days 1, 2, 3, 4, 5, 6, 7, 8, 9, 13, and 14) were tested with 
all three priors. All three chains were unstable and have not 
(6)ln (Vm,i )=N(3.54,0.12)+N(0.46,0.03) ln
MWTi
70kg
(7)ln (CLbo,i)=N(−0.16,0.17)+N(0.55,0.03) ln
BWTi
5kg
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converged successfully. No single-sample designs were 
considered further.
All combinations of permutations (i.e., multiple sample 
designs) for streamlined design A (where fewer paired sam-
ples that could be taken on any day from 1–14) and stream-
lined design B (where the duration of the study was limited 
to approximately a week and set to a maximum of 7-day, 
6-day, 5-day, 4-day, or 3-day studies) with low-information 
prior, mixed prior, and informative prior were tested, and the 
results are presented in Supplementary Material S8. The 
priors provided similar design performance. The low-infor-
mation prior resulted in chain instability in many runs and 
was therefore not considered further.
For streamlined design A, those promising designs for 
future field studies with good sensitivity and specificity val-
ues (i.e., close to one) are evaluated further for their appli-
cability with the design evaluation data set. For streamlined 
design B, many of the three-sample designs performed 
poorly in terms of sensitivity for the EBF classification. 
However, the designs with samples that extended to the first 
full week, e.g., on days 1, 5, or 7, performed satisfactorily. 
More intensive designs were considered, with many show-
ing good sensitivity and specificity. Of note, only the designs 
with mixed prior were evaluated.
Evaluation of the selected streamlined designs
Those potentially favorable streamlined designs with the 
mixed prior were evaluated against an independent data 
set that was not used in model building. Each evaluation 
data set (based on the streamlined designs) was created 
by sampling with replacement from the imputed full design 
evaluation data set. The sensitivity and specificity values 
Table 2. Breastfeeding classification by country 
Contents Non-EBF, n (%) EBF, n (%) Total
South Africa 43 (50) 43 (50) 86
Thailand 72 (63) 42 (37) 114
Kenya 31 (24) 96 (76) 127
Sri Lanka 5 (17) 25 (83) 30
India 0 (0) 15 (100) 15
Guatemala 7 (37) 12 (63) 19
Ghana 19 (70) 8 (30) 27
Chile 6 (21) 22 (79) 28
Indonesia 4 (3) 115 (97) 119
All countries 187 (33) 378 (67) 565
EBF, exclusive breastfeeding.
Figure 2. Individual visual predictive check for the best final model evaluation. Open circles are the observations. The solid lines 
(median, 2.5% and 97.5% quantiles) are the model-predicted response. D2O, deuterium oxide; EBF, exclusive breastfeeding.
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of these designs from the model-building data set and the 
design evaluation data set are listed side by side in Table 4. 
It can be seen that for many designs, the sensitivity and 
specificity are similar, which supports their potential utility 
for future field studies.
DISCUSSION
The currently used sampling protocol of the DTM deu-
terium technique requires 5–7 paired (mother and infant) 
saliva samples during a 14-day study period for the deter-
mination of individual breastfeeding practice that is then 
repeated across a region of interest to gather population 
characteristics. This requires the healthcare worker to visit 
the mother (often in remote locations) on several occasions 
and during the full study period at both significant cost to 
the study and inconvenience to the family. In this work, a 
streamlined sampling protocol was developed in which the 
DTM technique can be used with much less frequent sam-
pling follow-up to produce a field-friendly study. Here, it 
is considered that the streamlined designs that were less 
intensive in terms of either the number of paired samples 
or the duration of required study follow-up. In this work, it 
is critical to consider the performance of a streamlined de-
sign in its ability to correctly assign a mother–infant pair as 
either EBF or non-EBF. Rs is an individual parameter, and 
the assignment is performed at the individual level. The 
population characteristics of Rs are of less importance in 
this work. Therefore, all designs need to be stable and per-
form well for the individual.
Among all of the streamlined designs investigated, the 
two-sample and three-sample designs (Table 4) performed 
well for characterizing breastfeeding practice. For stream-
lined design A (the reduced-sampling intensity design), it 
was found that three-sample designs did not provide sig-
nificant extra benefits when compared with the two-sample 
designs. Of note, the standard deviations of the posterior 
distribution of Rs for these streamlined designs were simi-
lar between the analyses based on the model-building data 
set and design evaluation data set (i.e., at approximately 
30–40 g/day). From a practical standpoint, it would be pru-
dent to take an additional convenience sample (yielding a 
composite three-sample design that is optimal on two sam-
ples) to provide a buffer for execution error in the design.
Studies that addressed reduced study duration were 
described in streamlined design B, and the intention is 
to reduce the study duration from 14 days to 9 days as a 
maximum. The reduced designs nos. 19–21 (two-sample 
designs) and nos. 22–30 (three-sample designs) in Table 4 
perform equivalently well in terms of sensitivity and specific-
ity. To explore further the shortened protocols, it was consid-
ered here that the designs of greater intensity in terms of the 
number of samples but more parsimonious on study period. 
The results reveal that some of the designs have good clas-
sification performance. However, because of the increased 
number of samples in total, these designs might have limited 
use in field studies.
In this work, three priors were considered. However, the 
use of a mixed-information prior was primarily investigated 
Figure 3. Proportion of the imputed observations vs. the actual measured observations in the imputed full data set. Light gray bars 
represent the actual (measured) observations; dark gray bars represent the imputed (simulated) observations.
Table 3. Mixed prior 
Typical values BSV
Contents Mean SD Mean SD
ln(Vm) 3.45 0.01 0.15 0.01
ln(kmm) −2.18 0.01 0.18 0.01
ln(CLmb) 0 1,000 0 1,000
ln(CLbo) 0 1,000 0 1,000
kmm, rate constant, describing D2O total elimination from the mother com-
partment; Vm, D2O volume of distribution in mother compartment; CLmb, 
H2O clearance rate from mother to infant; CLbo, H2O clearance rate from 
infant. Typical values and between-subject variability ((BSV)  >  0) are as-
sumed as normal distribution, which is denoted here as mean and standard 
deviation (SD). For ln(Vm), ln(kmm), and their BSVs, the mean and SD values 
were set to the posterior of the base model analysis.
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and recommended in the future field studies. The intention 
of this prior is to contribute limited information on the param-
eters (CLmb and CLbo) that have a significant influence on the 
posterior distribution of Rs while being informative for those 
parameters that do not directly influence Rs (Vm and kmm). In 
this setting, the individual’s data would “speak” more to the 
parameters of interest. It is noted that when the information 
from the data is rich (i.e., the number of samples exceeds the 
number of parameters), the mixed-information and low-in-
formation priors performed equivalently. However, in the 
low-intensity designs explored here, the mixed-information 
prior was required to improve chain stability (it was observed 
in this study that mixed and informative priors were slightly 
better than the low-information prior). Deterministic identifi-
ability (used here to describe the dispersion of the posterior 
parameter density) together with chain stability are two im-
portant issues in this work. The dispersion of the density of 
Rs for those mother–infant pairs close to the cut-off value 
of 86.6 g/day is a determining factor in their classification 
as EBF (or otherwise). Rs is a function of model parameters 
(which are design dependent) and a number of design-in-
dependent random factors (e.g., absorption of atmospheric 
water by lungs and skin (Ra), water retaining rate for in-
fant’s growth (Rg), etc., see Supplementary Material S1). 
Hence, the mixed prior that provides low information on the 
model parameters that are informative of Rs and high in-
formation on the uninformative parameters provides a more 
stable solution. The lower bound on the dispersion of Rs is 
given by the dispersion of the design-independent random 
variables.
Table 4. Design validation (with the mixed prior)
No. Sampling days
Sensitivity Specificity
Besta Evaluationb Diff. Besta Evaluationb Diff.
Streamlined designs A
1 7 + 13 0.98 0.98 0.00 0.96 0.94 −0.02
2 7 + 14 0.98 0.96 −0.02 0.97 0.94 −0.03
3 8 + 13 0.99 0.98 −0.01 0.96 0.93 −0.03
4 8 + 14 0.99 0.97 −0.02 0.96 0.92 −0.04
5 9 + 13 0.99 0.98 −0.01 0.95 0.93 −0.02
6 9 + 14 0.99 0.98 −0.01 0.96 0.89 −0.07
7 2 + 7+13 0.98 0.99 0.01 0.94 0.88 −0.06
8 2 + 7+14 1.00 0.99 −0.01 0.94 0.89 −0.05
9 2 + 8+13 0.97 1.00 0.03 0.93 0.87 −0.06
10 2 + 8+14 0.99 1.00 0.01 0.93 0.89 −0.04
11 2 + 9+13 0.97 1.00 0.03 0.92 0.85 −0.07
12 2 + 9+14 0.99 1.00 0.01 0.92 0.87 −0.05
13 3 + 7+13 0.99 0.99 0.00 0.94 0.91 −0.03
14 3 + 7+14 1.00 1.00 0.00 0.93 0.86 −0.07
15 3 + 8+13 0.99 1.00 0.01 0.94 0.89 −0.05
16 3 + 8+14 1.00 1.00 0.00 0.93 0.85 −0.08
17 3 + 9+13 0.99 1.00 0.01 0.95 0.89 −0.06
18 3 + 9+14 0.99 1.00 0.01 0.93 0.86 −0.07
Streamlined designs B
19 5 + 7 0.98 0.99 0.01 0.94 0.89 −0.05
20 5 + 8 0.99 0.99 0.00 0.94 0.89 −0.05
21 5 + 9 0.98 0.99 0.01 0.95 0.89 −0.06
22 1 + 5+7 0.89 0.89 0.00 0.93 0.90 −0.03
23 1 + 5+8 0.91 0.95 0.04 0.94 0.90 −0.04
24 1 + 5+9 0.96 0.99 0.03 0.95 0.92 −0.03
25 2 + 5+7 0.93 1.00 0.07 0.94 0.89 −0.05
26 2 + 5+8 0.95 1.00 0.05 0.95 0.88 −0.07
27 2 + 5+9 0.97 1.00 0.03 0.95 0.87 −0.08
28 3 + 5+7 0.97 0.99 0.02 0.97 0.91 −0.06
29 3 + 5+8 0.99 0.99 0.00 0.97 0.92 −0.05
30 3 + 5+9 0.99 1.00 0.01 0.97 0.92 −0.05
Diff, value of “Evaluation” minus “Best.”
aBest = best streamlined design. These designs were identified and optimized from the imputed full model building data set. They were considered as 
potentially useful designs for future field studies.
bEvaluation = evaluation of the best streamlined designs. The imputed full model evaluation data set was used to validate the performance of the best 
streamlined designs.
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The design framework considered here was based on the 
optimal assignment of individuals to a dichotomous label 
given a pseudo-exhaustive search across potential stream-
lined designs. The criteria used in this work were based on 
the evaluation of the receiver operating characteristics of a 
design when compared with a reference design in terms of 
sensitivity and specificity. Hence, this work does not directly 
align with optimal design theory for parameter estimation 
(for which there are many software available10). Although it is 
possible to optimize the design for the estimation of a sub-
set of the parameters CLmb and CLbo, considered the most 
informative for the calculation of Rs, there is no guarantee 
that these designs would perform equivalently for the calcu-
lation of Rs and assignment to the EBF or non-EBF criteria. 
The design space was explored initially by assessing the 
sensitivity of the estimate of CLmb and CLbo to the sampling 
design (Supplementary Material S7 Figures S10 and S11) 
and found that the maximum information density of CLmb 
and CLbo occurred at sampling times day 4.5 and day 8. It 
was noted that the best two-sample designs required the 
first sample from days 7–9 and the second sample from 
days 13 or 14 as shown in nos. 1–6 of Table 4. It appears 
that the high sensitivity of the day 8 sample may be re-
flected in the two-sample designs; however, there is no 
clear alignment between the sensitivity of the design and 
that found to be optimal for classification.
In this study, sample imputation was needed to create 
the imputed full data set and consequently reduced to the 
streamlined data sets of interest. In this setting, a stream-
lined design was sampled nonparametrically from the 
imputed full data set for the assessment of its operating 
characteristics, and this sampling was conducted separately 
for each mother–infant pair. The influence of potential arte-
facts in the sampled designs across the population was not 
assessed and in practicality could not be assessed given the 
pseudo-exhaustive search conducted in this work. However, 
because a Bayesian framework was used in which the full 
posterior distributions of the parameters were estimated for 
each individual then the influence of a possibly erroneous 
data combination would have been reflected in the uncer-
tainty of the parameters that would affect the classification 
to non-EBF on a case-by-case basis. Given the performance 
criteria, sensitivity and specificity were based on the refer-
ence design (without imputation), and it is believed that the 
influence of any erroneous data would have been negligible. 
The ideal approach for this study would be to have 
data that arise from controlled EBF and controlled non-
EBF mother–infant pairs. This would then act as the gold 
standard from which full and reduced designs can be 
evaluated to evaluate the correct categorization of EBF 
or non-EBF. This approach is, however, not possible be-
cause controlled non-EBF data would require infants to be 
weaned for the purpose of the study, placing the infant at 
considerable risk, which would not be clinically or ethically 
appropriate. Our approach is to use an accepted model for 
deuterium DTM analysis6–8 as the basis for decisions on 
the operating characteristics of EBF designs and applying 
these to the uncontrolled model-building and design eval-
uation data sets.
CONCLUSIONS
The parsimonious designs identified in this work are 
intended to be applied in field studies and prospectively 
tested. When compared with the currently used 14-day 
studies that require 5–7 sample designs, the streamlined 
designs identified here have clear advantages in terms of 
convenience for the mothers, their families, and the re-
search staff. It is envisaged that the benefits of this work 
will improve the knowledge of the non-EBF characteristics 
of regional populations that could then lead to targeted in-
tervention programs.
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